Syantra
Because every woman deserves to be sure.
San Francisco Bay Area, Canada · Founded 2016 · $11.7M raised
- Headquarters
- San Francisco Bay Area
- Employees
- 1–10
- Founded
- 2016
- Business Model
- B2B
- Website
- syantra.com
- Total Funding
- $11.7M
- Last Round
- $6.8M Series ASep 2024
- Rounds
- 3
About
Syantra is a precision healthcare company developing Onco-ID™, a blood-based cancer detection platform that identifies cancer by detecting immune system response shifts rather than cancer cells directly. Its lead product is a whole-blood mRNA test for early breast cancer screening that is accurate in dense breast tissue where mammography struggles. The company is backed by a DoD-funded multi-center clinical study across the US and UK.
Summary
Syantra is a Healthcare company based in San Francisco Bay Area, Canada, founded in 2016. It has raised $11.7M in total across 3 rounds, most recently a $6.8M Series A round in Sep 2024.
Tech & App Stack
4 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Sep 2024
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
Global fertility clinics platform
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Biopharmaceutical services company
Specialty pharmaceutical company